ACRO Biomedical Co., Ltd. (6748) fair value: what the stock is really worth
As of Nov 20, 2026: fair value (intrinsic value) of ACRO Biomedical Co., Ltd. stock NT$79.24, price NT$150.50, that is 47.3% below the price, quality 24 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently applies, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
ACRO Biomedical Co., Ltd.
6748 · TWOFar too expensive (fair value 47% below the price) and weak company.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 21, 2026.
How to read this chart
12‑month range NT$59.80 – NT$295.50 · fair‑value band NT$59.43 – NT$99.05 · the NT$150.50 price screens above the NT$79.24 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 21, 2026.
Every Wednesday you see whether ACRO Biomedical Co. is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials. The company offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines.
Show moreShow less
The company was founded in 2014 and is based in Kaohsiung, Taiwan.
Stock analysis
ACRO Biomedical Co., Ltd. (6748) currently trades at NT$150.50, while our estimate is NT$79.24, 47% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently applies to this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: NT$59.43 (bear) to NT$99.05 (bull), the price of NT$150.50 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 24/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
ACRO Biomedical Co., Ltd. reported revenue of 38.3M TWD in FY2025 versus 21.8M TWD in FY2021, a compound +15.1%/yr. Reported net income was −82.7M TWD in FY2025.
Key figures
Market cap 12.8B TWD (≈ $387M) Small · EPS (TTM) NT$-1.20 · Net margin −149% · Return on equity −9.6% · Return on assets (EBIT) −15.3% (5-year average) · Operating margin −178% · Revenue (TTM) 52.8M TWD · Revenue growth (YoY) +109%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 49% below its 52-week high and 152% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −4% fair-value upside, at −47%, 6748 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare ACRO Biomedical Co., Ltd. with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 856 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Debt-to-equity by industry
- Price/FCF by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Taiwanese Stocks
- Valuation of the Taiwan market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $920.69 | $1,275.02 | +38% | vs 6748 |
| Vertex Pharmaceuticals Incorporated VRTX | $515.02 | $566.52 | +10% | vs 6748 |
| Samsung Biologics Co 207940 | ₩1,355,000 | ₩1,490,500 | +10% | vs 6748 |
| argenx SE ARGX | $925.70 | $908.40 | −2% | vs 6748 |
| CSL Limited CSL | A$197.29 | A$188.80 | −4% | vs 6748 |
| BeOne Medicines AG 6160 | HK$230.80 | HK$152.92 | −34% | vs 6748 |
| Moderna, Inc MRNA | $195.00 | $122.98 | −37% | vs 6748 |
| Revolution Medicines, Inc RVMD | $161.20 | $83.14 | −48% | vs 6748 |
| Celltrion, Inc 068270 | ₩213,000 | ₩74,574 | −65% | vs 6748 |
| Royalty Pharma plc RPRX | $68.45 | $19.01 | −72% | vs 6748 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is ACRO Biomedical Co., Ltd. (6748) overvalued or undervalued?
What is the fair value of 6748?
What is the quality score of 6748?
What is the price target for ACRO Biomedical Co., Ltd. (6748)?
What is the ACRO Biomedical Co., Ltd. stock forecast for 2026?
What is the revenue of ACRO Biomedical Co., Ltd. (6748)?
What is the intrinsic value of ACRO Biomedical Co., Ltd. (6748)?
Is ACRO Biomedical Co., Ltd. stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 6748?
How much is ACRO Biomedical Co., Ltd. worth?
What do the bullish and bearish scenarios say about 6748?
How solid is the balance sheet of ACRO Biomedical Co., Ltd. (6748)?
How far is 6748 from its 52-week high?
Which stocks are comparable to ACRO Biomedical Co., Ltd.?
Is ACRO Biomedical Co., Ltd. stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of ACRO Biomedical Co., Ltd. (6748)?
What should I pay attention to with ACRO Biomedical Co., Ltd. right now?
Key figures of ACRO Biomedical Co., Ltd.
How large is the market capitalisation of ACRO Biomedical Co., Ltd. (6748)?
What are the earnings per share of ACRO Biomedical Co., Ltd. (6748)?
What is the net margin of ACRO Biomedical Co., Ltd. (6748)?
What is the return on equity of ACRO Biomedical Co., Ltd. (6748)?
What is the EBIT return on assets of ACRO Biomedical Co., Ltd. (6748)?
What is the operating margin of ACRO Biomedical Co., Ltd. (6748)?
How fast is revenue growing at ACRO Biomedical Co., Ltd. (6748)?
How much free cash flow does ACRO Biomedical Co., Ltd. (6748) generate?
How much net cash does ACRO Biomedical Co., Ltd. (6748) hold?
Watch ACRO Biomedical Co., Ltd. in the live analysis
One click puts ACRO Biomedical Co., Ltd. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.